BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3556196)

  • 1. Kinetics of cellular oncogene expression in mouse lymphocytes. II. Regulation of c-fos and c-myc gene expression.
    Schneider-Schaulies J; Schimpl A; Wecker E
    Eur J Immunol; 1987 May; 17(5):713-8. PubMed ID: 3556196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of c-fos and c-myc expression during B cell activation by IL-4 and immunoglobulin binding ligands.
    Klemsz MJ; Justement LB; Palmer E; Cambier JC
    J Immunol; 1989 Aug; 143(3):1032-9. PubMed ID: 2787345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of cellular oncogene expression in mouse lymphocytes. I. Expression of c-myc and c-ras-Ha in T lymphocytes induced by various mitogens.
    Schneider-Schaulies J; Hünig T; Schimpl A; Wecker E
    Eur J Immunol; 1986 Mar; 16(3):312-6. PubMed ID: 3514240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes.
    Wingett D; Reeves R; Magnuson NS
    J Immunol; 1991 Nov; 147(10):3653-9. PubMed ID: 1940364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective T lymphocytes in old mice. Diminished production of mature c-myc RNA after mitogen exposure not attributable to alterations in transcription or RNA stability.
    Buckler AJ; Vie H; Sonenshein GE; Miller RA
    J Immunol; 1988 Apr; 140(7):2442-6. PubMed ID: 3280682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular oncogenes and lymphocyte activation.
    Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
    Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
    Rozengurt E; Sinnett-Smith JW
    J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-myc and c-fos gene regulation during mouse liver regeneration.
    Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
    Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals.
    Shipp MA; Reinherz EL
    J Immunol; 1987 Oct; 139(7):2143-8. PubMed ID: 2821108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of c-fos, c-jun, and c-myc genes is regulated by heat shock in human lymphoid cells.
    Bukh A; Martinez-Valdez H; Freedman SJ; Freedman MH; Cohen A
    J Immunol; 1990 Jun; 144(12):4835-40. PubMed ID: 2112575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
    Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
    Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential protooncogene expression during rat liver regeneration.
    Thompson NL; Mead JE; Braun L; Goyette M; Shank PR; Fausto N
    Cancer Res; 1986 Jun; 46(6):3111-7. PubMed ID: 3516391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
    Futscher BW; Erickson LC
    Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of afterload and angiotensin II on proto-oncogene mRNA levels in the isolated working rat heart.
    Roffe C; MacDiarmaid-Gordon A; Ohanian V; Hollis S; Heagerty AM
    Cardiovasc Res; 1996 Jun; 31(6):907-16. PubMed ID: 8759246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription of the c-myc oncogene is altered in spontaneously immortalized rodent fibroblasts.
    Tavassoli M; Shall S
    Oncogene; 1988 Apr; 2(4):337-45. PubMed ID: 3283652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
    St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
    Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative modes of c-myc regulation in growth factor-stimulated and differentiating cells.
    Nepveu A; Levine RA; Campisi J; Greenberg ME; Ziff EB; Marcu KB
    Oncogene; 1987; 1(3):243-50. PubMed ID: 2455262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional control of c-myc gene expression during stimulation of murine B lymphocytes.
    Buckler AJ; Rothstein TL; Sonenshein GE
    J Immunol; 1990 Jul; 145(2):732-6. PubMed ID: 2195118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple calcium-mediated mechanisms regulate c-myc expression in HL-60 cells.
    Salehi Z; Niedel JE
    J Immunol; 1990 Jul; 145(1):276-82. PubMed ID: 2113555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.